The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone

被引：0
|
作者：
Constance Delaby
Teresa Estellés
Nuole Zhu
Javier Arranz
Isabel Barroeta
María Carmona-Iragui
Ignacio Illán-Gala
Miguel Ángel Santos-Santos
Miren Altuna
Isabel Sala
M. Belén Sánchez-Saudinós
Laura Videla
Sílvia Valldeneu
Andrea Subirana
Mireia Tondo
Francisco Blanco-Vaca
Sylvain Lehmann
Olivia Belbin
Rafael Blesa
Juan Fortea
Alberto Lleó
Daniel Alcolea
机构：
[1] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,Sant Pau Memory Unit, Department of Neurology
[2] Universitat Autònoma de Barcelona,Servei de Bioquímica i Biologia Molecular
[3] IRMB,undefined
[4] INM,undefined
[5] Université de Montpellier,undefined
[6] INSERM,undefined
[7] CHU de Montpellier,undefined
[8] Laboratoire de Biochimie-Protéomique clinique,undefined
[9] Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas,undefined
[10] CIBERNED,undefined
[11] Fundació Catalana Síndrome de Down,undefined
[12] Centre Mèdic Down,undefined
[13] Servei de Bioquímica,undefined
[14] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,undefined
[15] Universitat Autònoma de Barcelona,undefined
[16] Unversitat Autònoma de Barcelona,undefined
[17] Centro de Investigación Biomédica en Red en Diabetes y Enfermedades Metabólicas (CIBERDEM),undefined
来源：
Alzheimer's Research & Therapy | / 14卷
关键词：
Amyloid; Aβ1–40; Aβ1–42; Cerebrospinal fluid; Tau; Biomarkers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone
    Delaby, Constance
    Estelles, Teresa
    Zhu, Nuole
    Arranz, Javier
    Barroeta, Isabel
    Carmona-Iragui, Maria
    Illan-Gala, Ignacio
    Santos-Santos, Miguel Angel
    Altuna, Miren
    Sala, Isabel
    Sanchez-Saudinos, M. Belen
    Videla, Laura
    Valldeneu, Silvia
    Subirana, Andrea
    Tondo, Mireia
    Blanco-Vaca, Francisco
    Lehmann, Sylvain
    Belbin, Olivia
    Blesa, Rafael
    Fortea, Juan
    Lleo, Alberto
    Alcolea, Daniel
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [2] Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau
    Lewczuk, P
    Esselmann, H
    Otto, M
    Maler, JM
    Henkel, AW
    Henkel, MK
    Eikenberg, O
    Antz, C
    Krause, WR
    Reulbach, U
    Kornhuber, J
    Wiltfang, J
    NEUROBIOLOGY OF AGING, 2004, 25 (03) : 273 - 281
  • [3] Tau pathogenesis is promoted by Aβ1-42 but not Aβ1-40
    Hu, Xiaoyan
    Li, Xiaoling
    Zhao, Mingrui
    Gottesdiener, Andrew
    Luo, Wenjie
    Paul, Steven
    MOLECULAR NEURODEGENERATION, 2014, 9 : 52
  • [4] Tau pathogenesis is promoted by Aβ1-42 but not Aβ1-40
    Xiaoyan Hu
    Xiaoling Li
    Mingrui Zhao
    Andrew Gottesdiener
    Wenjie Luo
    Steven Paul
    Molecular Neurodegeneration, 9
  • [5] CSF tau and amyloid β1-42 (Aβ42) as possible biomarkers of Alzheimer disease
    Ravid, R
    Kamphorst, W
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S298 - S298
  • [6] Significant discrepancies in amyloid status A plus /A- in CSF based on Aβ1-42 measurement or Aβ1-42/Aβ1-40 ratio.
    Tisserand, C.
    Gouilly, D.
    Benaiteau, M.
    Rafiq, M.
    Nogueira, L.
    Pariente, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 260 - 260
  • [7] Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42/Aβ1-40 ratio - a cross-validation study against amyloid PET
    Pannee, Josef
    Portelius, Erik
    Minthon, Lennart
    Gobom, Johan
    Andreasson, Ulf
    Zetterberg, Henrik
    Hansson, Oskar
    Blennow, Kaj
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 (04) : 651 - 658
  • [8] CSF Extracellular Vesicle Aβ42 and Tau/Aβ42 Ratio Are Associated with Cognitive Impairment in Older People with HIV
    Guha, Debjani
    Misra, Vikas
    Chettimada, Sukrutha
    Yin, Jun
    Gabuzda, Dana
    VIRUSES-BASEL, 2024, 16 (01):
  • [9] Amyloid β(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease
    Schoonenboom, NSM
    Pijnenburg, YAL
    Mulder, C
    Rosso, SM
    Van Elk, EJ
    Van Kamp, GJ
    Van Swieten, JC
    Scheltens, P
    NEUROLOGY, 2004, 62 (09) : 1580 - 1584
  • [10] CSF levels of β-amyloid 1-42, tau and phosphorylated tau protein in CADASIL
    Formichi, P.
    Parnetti, L.
    Radi, E.
    Cevenini, G.
    Dotti, M. T.
    Federico, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (11) : 1252 - 1255
12345